Art Mandell
Director/Miembro de la Junta en MAXCYTE, INC. .
Fortuna: 1 M $ al 30/04/2024
Relaciones activas
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Doug Doerfler | M | 68 |
MdBio, Inc.
 MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | 26 años |
| Maher Masoud | M | 49 | - | |
| Ron Holtz | M | 66 | 19 años | |
| Richard Douglas | M | 71 | 6 años | |
| Patrick Balthrop | M | 67 | 2 años | |
| Rekha Hemrajani | F | 54 | 3 años | |
| Yasir Al-Wakeel | M | 42 | 3 años | |
| Douglas Swirsky | M | 54 | 1 años | |
| John Johnston | M | 65 | 8 años | |
| Stanley Erck | M | 76 | 19 años | |
| Kenneth Carter | M | 65 |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006.
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 años |
| Will Brooke | M | 68 | 20 años | |
| Richard Danzig | M | 80 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 23 años |
| David Sandoval | M | 46 | 1 años | |
| Rachel King | F | 64 |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | - |
| Jerry L. Parrott | M | - |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | - |
| John Joseph Woloszyn | M | - |
MdBio, Inc.
MdBio, Inc. Miscellaneous Commercial ServicesCommercial Services MdBio, Inc. is based in Frederick, MD. MdBio provides medical-grade, patient-tested full spectrum hemp and plant-based medicine products that are unique in the industry for their innovation, quality, and potency. Targeting ailments such as poor sleep, anxiety, pain, and weakened immune systems, their products naturally restore the body's endocannabinoid balance to maximize overall health and wellbeing in patients. Part of Maryland Technology Council, MdBio, Inc. is a company founded by four renowned medical doctors committed to providing therapeutic alternatives to pharmaceutical drugs. MdBio was acquired by Tech Council of Maryland, Inc. on February 07, 2006. | - |
| Thomas Ross | M | 63 | 10 años | |
| James Brady | M | - | - | |
| Steven Nardi | M | - | 4 años | |
| Jill Mayer | F | - | 6 años | |
| Gene Zhu | M | - | - | |
| Ali Soleymannezhad | M | - | 1 años |
Gráfico relacional
Relaciones con varias empresas
Antiguas relaciones
| Nombre | Sexo | Edad | Empresas relacionadas | Colaboración |
|---|---|---|---|---|
| Melvin Booth | M | 79 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 años |
| Bradley Calvin | M | - | - | |
| Bradley G. Lorimier | M | 78 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 años |
| J. Stark Thompson | M | 82 | 20 años | |
| James H. Davis | M | 72 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 15 años |
| William W. Freimuth | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 12 años |
| Darren W. Buchwald | M | 54 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 5 años |
| Jarrod Longcor | M | 51 | 1 años | |
| Michele M. Wales | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Ann L. Wang | F | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Linda N. Liu | M | 57 | 7 años | |
| Sarah Haecker Meeks | M | - | 4 años | |
| Debra K. Bowes | F | - | 3 años | |
| Viktor Roschke | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 8 años |
| Thi-Sau Migone | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Pierre V. Verroye | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| James Lovgren | M | - | - | |
| Claudio Dansky Ullmann | M | - | - | |
| Thomas Spitznagel | M | 57 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 14 años |
| Joseph A. Morin | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Karen A. Donato | M | - | - | |
| Andrew Dunlop | M | 52 | - | |
| Amanda L. Murphy | F | 47 | 2 años | |
| Jonathan M. Cool | M | 64 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 3 años |
| Vivian R. Albert | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Sally D. Bolmer | M | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 años |
| Madhusudan V. Peshwa | M | - | - | |
| Kathryn de Santis | F | - |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Dennis Dougherty | M | 76 | - | |
| Jürgen Drews | M | 91 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 años |
| Richard C. Holbrooke | M | 82 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| David Stump | M | 74 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 13 años |
| Susan D. Bateson | F | 69 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Laura Tyson | M | 76 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | - |
| Cenk Sumen | M | 51 | 2 años |
Estadísticas
| País | Relaciones | % del total |
|---|---|---|
| Estados Unidos | 58 | 100.00% |
Antigüedad de la relación
Activas
Pasados
Hombre
Mujer
Administradores
Ejecutivos
Origen de las relaciones
- Bolsa de valores
- Insiders
- Art Mandell
- Red Personal
